Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion

Johnan A R Kaleeba1, Edward A Berger

  • 1Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 237, Bethesda, MD 20892, USA.

Virology
|August 8, 2006
PubMed

Insights

Kaposi's sarcoma-associated herpesvirus (KSHV) entry mechanisms were investigated using cell fusion and virion entry assays. Findings reveal specific cell types are permissive to KSHV, suggesting a novel fusion-entry receptor.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • The entry mechanism of Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, remains largely undefined.
  • Understanding KSHV entry is crucial for developing targeted therapeutic strategies against KSHV-associated diseases.

Purpose of the Study:

  • To identify and characterize target cells permissive to KSHV entry.
  • To elucidate the molecular basis of KSHV-mediated cell fusion and virion entry.

Main Methods:

  • Utilized a quantitative reporter gene assay for KSHV-glycoprotein-mediated cell fusion across diverse cell types.
  • Employed a virion entry assay with a recombinant KSHV encoding a reporter gene.
  • Assessed surface expression of alpha3beta1 integrin on target cells.

Main Results:

  • Human, non-human primate, and rabbit cell lines demonstrated efficient KSHV target cell activity.
  • Rodent and human lymphoblastoid cell lines exhibited weak permissiveness to KSHV.
  • No correlation was found between target cell permissiveness and alpha3beta1 integrin surface expression.

Conclusions:

  • Target cell permissiveness for KSHV entry is cell-type dependent and species-specific.
  • The findings suggest the existence of a putative KSHV fusion-entry receptor distinct from alpha3beta1 integrin.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...